Antisense Oligonucleotide Clinical Guidance Emphasizes Individualized Nature Of Treatment

 
• By Sue Sutter
  
Flowers in field
In FDA's view, a study for an individualized ASO therapy will involve 1 or 2 patients. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet